Overview

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

Status:
Completed
Trial end date:
2020-10-26
Target enrollment:
Participant gender:
Summary
A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D759 and D150
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical